Characterization of a 2,4-dinitrochlorobenzene-induced chronic dermatitis model in rats

Skin Pharmacology and Physiology

Volumn 22, Issue 5, 2009, Pages 240-247

  Fujii, Y ^a,b   Takeuchi, H ^a   Sakuma, S ^a   Sengoku, T ^a   Takakura, S ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b NONE   (Japan)

Author keywords

Allergic contact dermatitis; Atopic dermatitis; Tacrolimus

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; BROWN NORWAY RAT; CONTROLLED STUDY; EAR; EOSINOPHIL; EXPERIMENTAL MODEL; LYMPHOCYTIC INFILTRATION; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCRATCHING; SKIN ALLERGY; T LYMPHOCYTE;

ANIMALS; CHRONIC DISEASE; DERMATITIS, ATOPIC; DINITROCHLOROBENZENE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; EAR; HAPTENS; MALE; RATS; RATS, INBRED BN; TIME FACTORS;

EID: 68749087540     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235551     Document Type: Article

References (42)

1. Leung DYM: Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302-318.
2. Boguniewicz M, Leung DYM: Pathophysiologic mechanisms in atopic dermatitis. Semin Cutan Med Surg 2001;20:217-225.
3. Cooper KD: Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-137. (Pubitemid 24039577)
4. Friedmann PS, Tan BB, Musaba E, Strickland I: Pathogenesis and management of atopic dermatitis. Clin Exp Allergy 1995;25:799-806.
5. Eedy DJ: What's new in atopic dermatitis? Br J Dermatol 2001;145:380-384.
6. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C: Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-466. (Pubitemid 27113270)
7. Hiroi J, Sengoku T, Morita K, Kishi S, Sato S, Ogawa T, Tsudzuki M, Matsuda H, Wada A, Esaki K: Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice. Jpn J Pharmacol 1998;76:175-183. (Pubitemid 28140410)
8. Takano N, Arai I, Kurachi M: A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice. Br J Dermatol 2006;154:426-430. (Pubitemid 43382647)
9. Sasakawa T, Higashi Y, Sakuma S, Hirayama Y, Sasakawa Y, Ohkubo Y, Goto T, Matsumoto M, Matsuda H: Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC/Nga mice. Int Arch Allergy Immunol 2001;126:239-247. (Pubitemid 34042832)
10. Konishi H, Tsutsui H, Murakami T, Yumikura-Futatsugi S, Yamanaka K, Tanaka M, Iwakura Y, Suzuki N, Takeda K, Akira S, Nakanishi K, Mizutani H: IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci USA 2002;99:11340-11345. (Pubitemid 34920927)
11. Shiohara T, Hayakawa J, Mizukawa Y: Animal models for atopic dermatitis: are they relevant to human disease? J Dermatol Sci 2004;36:1-9.
12. Kitagaki H, Fujisawa S, Watanabe K, Hayakawa K, Shiohara T: Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J Invest Dermatol 1995;105:749-755. (Pubitemid 26006351)
13. Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T: Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 1997;159:2484-2491. (Pubitemid 127681044)
14. Webb EF, Tzimas MN, Newsholme SJ, Griswold DE: Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor α and interleukin-4. J Invest Dermatol 1998;111:86-92.
15. Arfsten DP, Garrett CM, Jederberg WW, Wilfong ER, McDougal JN: Characterization of the skin penetration of a hydrocarbon-based weapons maintenance oil. J Occup Environ Hyg 2006;3:457-464.
16. Traidl C, Jugert F, Krieg T, Merk H, Hunzelmann N: Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol 1999;112:476-482. (Pubitemid 29171938)
17. Groen H, Klatter FA, van Petersen AS, Pater JM, Nieuwenhuis P, Kampinga J: Composition of rat CD4+ resting memory T cell pool is influenced by major histocompatibility complex. Transplant Proc 1993;25:2782-2783. (Pubitemid 23314234)
18. Tarayre JP, Aliaga M, Barbara M, Tisseyre N, Vieu S, Tisne-Versailles J: Model of bronchial allergic inflammation in the Brown Norway rat: pharmacological modulation. Int J Immunopharmacol 1992;14:847-855.
19. Sapienza S, Renzi PM, Martin JG: Effects of ketotifen on airway responses to allergen challenge in the actively sensitized Brown Norway rat. Agents Actions 1992;37:238-244. (Pubitemid 23062752)
20. Simpson D, Noble S: Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions. Drugs 2005;65:827-858. (Pubitemid 40598095)
21. 2 receptor involvement in acute 5-HT-evoked scratching but not in allergic pruritus induced by dinitrofluorobenzene in rats. J Pharmacol Exp Ther 2003;306:245-252.
22. Plitz T, Saint-Mézard P, Satho M, Herren S, Waltzinger C, Bittencourt MC, Kosco-Vilbois MH, Chvatchko Y: IL-18 binding protein protects against contact hypersensitivity. J Immunol 2003;171:1164-1171. (Pubitemid 36900044)
23. Müller KM, Jaunin F, Masouye I, Saurat JH, Hauser C: Th2 cells mediate IL-4-dependent local tissue inflammation. J Immunol 1993;150:5576-5584. (Pubitemid 23180672)
24. Haanen JBAG, de Malefijt RD, Res PCM, Kraakman EM, Ottenhoff THM, de Vries RRP, Spits H: Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 1991;174:583-592.
25. Lewis DB: Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy? Curr Opin Immunol 2002;14:644-651.
26. Yosipovitch G, Fleischer AB: Itch associated with skin disease - advances in pathophysiology and emerging therapies. Am J Clin Dermatol 2003;4:617-622. (Pubitemid 37114950)
27. Weisshaar E, Kucenic MJ, Fleischer AB: Pruritus: a review. Acta Derm Venereol Suppl 2003;213:5-32.
28. Kuraishi Y, Nagasawa T, Hayashi K, Satoh M: Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 1995;275:229-233.
29. Yamashita H, Michibata Y, Mizukami H, Ogihara Y, Morita A, Nose M: Dermal mast cells play a central role in the incidence of scratching behavior in mice induced by multiple application of the hapten, 2,4,6-trinitrochlorobenzen. Exp Dermatol 2005;14:438-444.
30. Ständer S, Steinhoff M: Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 2002;11:12-24. (Pubitemid 36934620)
31. Reitamo S, Van Leent EJM, Ho V, Harper J, Ruzicka T, Kalimo K, Cambazard F, Rustin M, Taieb A, Gratton D, Sauder D, Sharpe G, Smith C, Junger M, de Prost Y: Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002;109:539-546. (Pubitemid 34234208)
32. Reitamo S, Rustin M, Ruzicka T, Cambazard F, Kalimo K, Friedmann PS, Schoepf E, Lahfa M, Diepgen TL, Judodihardjo H, Wollenberg A, Berth-Jones J, Bieber T: Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002;109:547-555. (Pubitemid 34234209)
33. Reitamo S, Wollenberg A, Schopf E, Perrot JL, Marks R, Ruzicka T, Christophers E, Kapp A, Lahfa M, Rubins A, Jablonska S, Rustin M: Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000;136:999-1006. (Pubitemid 30629127)
34. Sato K, Sugibayashi K, Morimoto Y: Species differences in percutaneous absorption of nicorandil. J Pharm Sci 1991;80:104-107.
35. Mizojiri K, Okabe H, Sugeno K, Esumi Y, Takaichi M, Miyake T, Seki H, Inaba A: Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid - 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats. Arzneimittelforschung 1997;47:59-69.
36. Mizojiri K, Okabe H, Sugeno K, Misaki A, Ito M, Kominami G, Esumi Y, Takaichi M, Harada T, Seki H, Inaba A: Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl) carbamoyl] benzoic acid - 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. Arzneimittelforschung 1997;47:259-269.
37. Boogaard PJ, Denneman MA, Van Sittert NJ: Dermal penetration and metabolism of five glycidyl ethers in human, rat and mouse skin. Xenobiotica 2000;30:469-483.
38. Mahler J: NTP technical report on the toxicity studies of black newsprint inks administered topically to F344/N rats and C3H mice. Toxic Rep Ser 1992;17:1-E2.
39. Meingassner JG, Stütz A: Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 1992;98:851-855.
40. Meingassner JG, Grassberger M, Fahrngruber H, Moore HD, Schuurman H, Stütz A: A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology. Br J Dermatol 1997;137:568-576. (Pubitemid 27469508)
41. Geba GP, Ptak W, Askenase PW: Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity. Immunology 2001;104:235-242. (Pubitemid 32989524)
42. Jiang H, Sakuma S, Fujii Y, Akiyama Y, Ogawa T, Tamura K, Kobayashi M, Fujitsu T: Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival. Transpl Int 1999;12:92-99. (Pubitemid 29209707)